COVID-19死亡的种族差异可能是由于雄激素受体基因变异与前列腺癌和雄激素性脱发有关。抗雄激素是COVID-19的潜在治疗方法吗?

PubMed ID
G H
发表日期 2020年Jul月

原始出处 美容皮肤病杂志
Journal of cosmetic dermatology
作者 McCoy  John  Wambier  Carlos G  Vano-Galvan  Sergio  Shapiro  Jerry  Sinclair  Rodney  Ramos  Paulo Müller  Washenik  Kenneth  Andrade  Murilo  Herrera  Sabina  Goren  Andy 

文献标题 COVID-19死亡的种族差异可能是由于雄激素受体基因变异与前列腺癌和雄激素性脱发有关。抗雄激素是COVID-19的潜在治疗方法吗?
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?

文献摘要


获取全文 10.1111/jocd.13455